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ReviewThe Conformational Plasticity
of Protein Kinases
the transfer of the -phosphate of ATP to the hydroxyl
group of serine, threonine, or tyrosine. Thus, upon acti-
vation they all adopt catalytically active on conforma-
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Palo Alto, California 94305 tions that are structurally very similar (Knighton et al.,
1991; Jeffrey et al., 1995; Yamaguchi and Hendrickson,2 Department of Molecular and Cell Biology
Department of Chemistry 1996; Canagarajah et al., 1997; Hubbard, 1997). The off
states of protein kinases are not subject to the chemicalHoward Hughes Medical Institute
University of California, Berkeley constraints that the active states must satisfy, and so
different classes of kinases have evolved distinct offBerkeley, California 94720
3 Physical Biosciences Division states in which the adoption of the catalytically active
conformation is impeded in different ways.Lawrence Berkeley National Laboratory
Berkeley, California 94720 In this review we survey the conformational changes
undergone by Ser/Thr and Tyr kinase domains as they
turn on and off. After briefly introducing the structure of
the kinase domain in the active state, we discuss twoProtein kinases operate in a large number of distinct
signaling pathways, where the tight regulation of their key regulatory elements within the domain, the activa-
tion loop and the C helix. We then discuss severalcatalytic activity is crucial to the development and
maintenance of eukaryotic organisms. The catalytic kinases that have been analyzed structurally in their
inactive states.domains of different kinases adopt strikingly similar
structures when they are active. By contrast, crystal
structures of inactive kinases have revealed a remark- The Structure of the Kinase Domain
able plasticity in the kinase domain that allows the in the On State
adoption of distinct conformations in response to in- The three-dimensional structure of a eukaryotic protein
teractions with specific regulatory domains or pro- kinase domain was first visualized by X-ray crystallogra-
teins. phy in the case of cyclic AMP-dependent protein kinase,
a Ser/Thr kinase also known as protein kinase A (PKA)
The importance of protein phosphorylation in eukaryotic (Knighton et al., 1991). Of particular importance for un-
signaling is reflected in the fact that protein kinase do- derstanding the on state of kinases is the structure of
mains are found in 2% of eukaryotic genes (Rubin et PKA in complex with Mn-ATP and the substrate mimic
al., 2000). The spatial and temporal control of phosphor- PKI, which captures the protein kinase in a conformation
ylation of specific serine, threonine, or tyrosine residues that is primed and ready for phosphotransfer (Knighton
is crucial to cellular growth and development, and this et al., 1991; Bossemeyer et al., 1993; Zheng et al., 1993).
control relies on the proper regulation of protein kinases. The protein kinase fold, which is extremely well con-
Kinase activity in the wrong place or at the wrong time served among serine/threonine and tyrosine kinases, is
can have disastrous consequences, often leading to cell separated into two subdomains, or lobes (Figure 1). The
transformation and cancer. Indeed, the first oncogene to smaller N-terminal lobe, or N lobe, is composed of a
be discovered, v-Src, encodes an aberrantly regulated five-stranded  sheet and one prominent  helix, called
tyrosine kinase (Levinson et al., 1978; Eckhart et al., helix C. The C lobe is larger and is predominantly heli-
1979). cal. ATP is bound in a deep cleft between the two lobes
The serine/threonine and tyrosine kinases are a fasci- and sits beneath a highly conserved loop connecting
nating study in molecular evolution. On the basis of strands 1 and 2. This phosphate binding loop, or P
sequence and structure, these enzymes form a closely loop, contains a conserved glycine-rich sequence motif
related superfamily that is distinct from the histidine (GXGXφG) whereφ is usually tyrosine or phenylalanine.
kinases and other phosphotransfer enzymes. While the The glycine residues allow the loop to approach the
several hundred eukaryotic protein kinases all contain phosphates of ATP very closely and to coordinate them
the same catalytic scaffold, a number of very different via backbone interactions. The conserved aromatic side
regulatory mechanisms have evolved that allow individ- chain caps the site of phosphate transfer. The glycine
ual members of the family to function downstream of residues make the P loop very flexible in the absence of
the specialized input signals that turn them on. Protein ATP, a fact that facilitates the binding of small molecule
kinases are usually kept off, and the acquisition of cata- inhibitors. Some of these inhibitors induce large struc-
lytic activity is often buried under multiple layers of con- tural distortions in the loop by interacting with the con-
trol, ranging from the binding of allosteric effectors to served aromatic residue (Mohammadi et al., 1997;
alterations in the subcellular localization of the enzyme. Schindler et al., 2000).
Protein kinases are molecular switches that can adopt Peptide substrate binds in an extended conformation
at least two extreme conformations: an “on” state that across the front end of the nucleotide binding pocket,
is maximally active, and an “off” state that has minimal close to the -phosphate of ATP. A centrally located
activity. All protein kinases catalyze the same reaction, loop known as the “activation loop,” typically 20–30
residues in length, provides a platform for the peptide
substrate. In PKA, as in most kinases, this loop is phos-4 Correspondence: kuriyan@uclink.berkeley.edu
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Figure 1. The Catalytically Active Conformation of the Protein Kinase Domain
(Top) The crystal structures of protein kinase A (PKA, a serine/threonine kinase) (Zheng et al., 1993) and insulin receptor kinase (IRK, a tyrosine
kinase) (Hubbard, 1997) are shown in ribbon representation. Key structural elements within the kinase domain are colored as follows: activation
loop, red; C helix, purple; P loop, orange; and catalytic loop, green. The peptide substrate for IRK as well as the PKI peptide inhibitor for
PKA are colored yellow. Bound nucleotide and several absolutely conserved residues within the active site are indicated. Also shown is the
structure of unphosphorylated, inactive IRK (Hubbard et al., 1994). In the unphosphorylated state, the activation segment of IRK adopts a
conformation that impedes the binding of nucleotide and peptide substrate.
(Bottom) The three structures have been schematized to clearly depict the conformational transitions involved in the regulation of kinase
activity, with particular emphasis on the C helix and activation loop. The catalytic lysine and glutamate (Lys72 and Glu91 in PKA) are shown
in each schematic.
phorylated when the kinase is active. Phosphorylation of the C helix. The integrity of the Lys72-Glu91 ion pair
is important for activity and will be discussed below.the activation loop stabilizes it in an open and extended
conformation that is permissive for substrate binding.
Optimal phosphotransfer requires the precise spatial Conformational Changes in the Activation Loop
arrangement of several catalytic residues that are abso- The activation loop has the capacity to undergo large
lutely conserved among all known kinases. Asp166 and conformational changes when the kinase switches be-
Asn171 (PKA numbering) emanate from a highly con- tween inactive and active states (Johnson et al., 1996).
served loop structure at the base of the active site, called For example, insulin receptor kinase (IRK) is activated
the catalytic loop. Asp166 interacts with the attacking by phosphorylation of three tyrosine residues within its
hydroxyl side chain of the substrate, while Asn171 en- activation loop (Figure 1). In the unphosphorylated state,
gages in hydrogen bonding interactions that orient the activation loop collapses into the active site,
Asp166. Asn171 and another absolutely conserved cata- blocking the binding of both nucleotide and peptide
lytic residue, Asp184, are also required for the binding of substrate (Hubbard et al., 1994). Upon phosphorylation,
two divalent cations involved in nucleotide recognition. it moves away from the catalytic center and adopts a
Asp184 forms part of the highly conserved Asp-Phe-Gly conformation that allows substrate binding and cataly-
motif situated at the base of the activation loop. The sis (Hubbard, 1997). In a number of kinases, including
structure of this motif, and in particular the conformation IRK, these conformational changes involve crankshaft-
of Asp184, is tightly coupled to phosphorylation of the like motions in the N-terminal portion of the activation
activation loop. In the N lobe, Lys72 makes crucial con- loop that result in the proper orientation of the conserved
tacts with the - and -phosphate groups, positioning Asp-Phe-Gly sequence within the active site (Hubbard
them properly for catalysis. Lys72 is buried deep within et al., 1998).
the interlobe cleft, where it is stabilized and oriented The placement and total number of phosphorylation
sites within the activation loop varies from kinase toproperly by an ionic interaction with Glu91, a residue in
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close sequence similarity within the nucleotide recogni-
tion pocket (Zimmermann et al., 1997). Thus, the specific
binding of Gleevec to Abl and not to Src depends on
the capacity of the activation loop to adopt a particular
conformation.
Coupling between the C Helix
and the Activation Loop
Helix C, the only conserved helix in the  sheet-rich N
lobe, is an important mediator of conformational
changes that take place within the catalytic center. An
absolutely conserved glutamate residue (Glu91 in PKA)
is located within this helix, and in active kinases this
residue forms an ion pair with the lysine side chain
(Lys72 in PKA) that coordinates the  and  phosphates
of ATP. The C helix also makes direct contact with the
N-terminal region of the activation loop, and its confor-Figure 2. The Regulation of MAP Kinase by Phosphorylation of the
mation is often linked to that of the conserved Asp-Phe-Activation Segment
Gly motif. This interaction, along with the Glu91-Lys72Phosphorylation of the activation segment creates a network of
interactions that properly orient the C helix, promote lobe closure, ion pair, directly couples the conformation of the helix
and organize the C-terminal extension (shown in yellow) into a func- to nucleotide binding. Regulatory mechanisms often
tionally important homodimerization interface (Zhang et al., 1994; modulate kinase activity by altering the conformation of
Canagarajah et al., 1997; Khokhlatchev et al., 1998). helix C, thereby affecting the integrity of these interac-
tions.
The cyclin-dependent kinase (CDK) family provideskinase. One phosphate usually adopts a central position,
where it forms an ion pair with a conserved arginine one of the clearest examples of allosteric regulation
of catalytic activity via helix C (Figure 3). CDKs are(Arg165 in PKA) situated in the catalytic loop (Knighton
et al., 1991; Russo et al., 1996; Yamaguchi and Hendrick- catalytically inactive on their own but become active
upon binding cognate cyclins. In the absence of cyclin,son, 1996; Canagarajah et al., 1997). This ion-pairing
interaction is likely to be important in rotating the Asp- the C helix (also called the PSTAIRE helix in CDKs for
a conserved cyclin recognition motif within it) is rotatedPhe-Gly motif into proper orientation for catalysis. Phos-
phorylation at the central position can also nucleate outward about its long axis relative to its position in
PKA (DeBondt et al., 1993). This swings the conservedinteractions that propagate well into the N lobe. For
example, the mitogen-activated protein (MAP) kinase glutamate (Glu51 in CDK2) out of the active site and
disrupts its interaction with the lysine that coordinatesERK2 undergoes phosphorylation at a threonine and a
tyrosine residue within the activation loop (Figure 2). Of ATP (Lys33 in CDK2). Cyclin binds directly to the C
helix and surrounding elements in the kinase N lobe,these, pThr183 occupies the central coordinating posi-
tion, forming contacts that extend to the C helix, inducing the reverse rotation that restores the Lys33-
Glu51 ion pair (Jeffrey et al., 1995).thereby promoting closure of the N and C lobes such
that the kinase becomes active (Canagarajah et al., Conformational changes in helix C are a crucial fea-
ture of the activation mechanism of the Src family tyro-1997). This network of interactions also plays a key role
in modulating the oligomerization state of ERK2. MAP sine kinases as well (Sicheri et al., 1997; Xu et al., 1997).
Src family members bear an SH3 domain and an SH2kinases have a C-terminal extension that binds to the
surface of the N lobe, near helix C (Zhang et al., 1994). domain N-terminal to their kinase core and are regulated
by phosphorylation of a tyrosine residue in their C-ter-Phosphorylation at Thr183 in the activation loop induces
a conformational change in this C-terminal extension, minal tail (Tyr527 in Src). Phosphorylation of Tyr527 in-
hibits Src activity by engaging the SH2 domain in anexposing a hydrophobic surface that facilitates the for-
mation of homodimers (Canagarajah et al., 1997). Dimer- intramolecular interaction (Figure 3). This positions the
SH3 domain so as to interact with the linker connectingization via this interface is required for the nuclear local-
ization of the enzyme (Khokhlatchev et al., 1998). the SH2 and kinase domains. The interaction with the
SH3 domain induces the linker to adopt the type II poly-The ability of the activation loops of different kinases
to adopt distinct conformations when the kinase is off proline helical conformation, characteristic of SH3 do-
main ligands. The SH3 domain and linker bind to thehas recently been exploited to great medical benefit.
The anticancer drug Gleevec is a potent therapeutic in surface of the N lobe of the kinase, stabilizing helix C
in an inactive conformation that is very similar to thatthe treatment of chronic myelogenous leukemia, and
it acts by inhibiting the kinase activity of the Bcr-Abl of the CDK PSTAIRE helix in the absence of cyclin.
Ligands of the SH2 and SH3 domains activate Srconcoprotein directly (Druker et al., 2001). Gleevec binds
to an inactive form of Abl kinase selectively, stabilizing family kinases by disrupting the interactions described
above and allowing helix C to assume an active confor-the activation loop in a conformation that mimics bound
substrate (Schindler et al., 2000). The closely related Src mation (Moarefi et al., 1997; Gonfloni et al., 2000). While
the structural details of the conformational changes infamily kinases display an entirely different activation
loop conformation in their inactive states (Schindler et the C helix are quite similar between Src and CDK, it
is interesting that the thermodynamics of the switchingal., 1999; Xu et al., 1999) and do not bind Gleevec despite
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Figure 3. The Regulation of Cyclin-Dependent Kinase (CDK) and Src Tyrosine Kinase
In the absence of cyclin, the C helix of CDK (also called the PSTAIRE helix) is rotated so as to move a crucial catalytic glutamate out of the
active site (DeBondt et al., 1993). This is correlated with an inhibitory conformation of the activation loop. Cyclin binding reorients the PSTAIRE
helix so as to place the glutamate within the active site (Jeffrey et al., 1995). The activation loop adopts a near-active conformation upon
cyclin binding, and its subsequent phosphorylation further stabilizes the active form (Russo et al., 1996). In Src, intramolecular interactions
between the phosphorylated tail and the SH2 domain, and between the SH2-kinase linker and the SH3 domain, stabilize inhibitory conformations
of both helix C and the activation loop (Schindler et al., 1999; Xu et al., 1999). The conformation of C in the off state is quite similar to that
seen in CDK. Disengagement of the SH2 domain by dephosphorylation of the tail (at Tyr527), combined with phosphorylation of the activation
loop (at Tyr416), allows the C helix to move into an active conformation.
process have been tailored differently in these two This structural coupling between C and the activa-
tion loop is also manifested at a functional level. Dis-cases. With CDK, the binding of cyclin activates the
enzyme, while with Src, the binding of the SH3 domain placement of the SH3 domain in Hck, for example, stimu-
lates autophosphorylation of the activation loop tyrosineand linker stabilizes the inhibited state.
The story is not so simple, however. Both CDKs and (Tyr416 in Src), presumably via the C helix (Moarefi
Src family kinases also require phosphorylation of the et al., 1997). Reciprocally, phosphorylation at Tyr416
activation loop to achieve full activity. The activation weakens the affinity of the SH3 and SH2 domains for
loops of both proteins adopt conformations that block their intramolecular targets in the kinase N lobe and tail,
the binding of peptide substrates in the unphosphory- respectively (Gonfloni et al., 2000; Porter et al., 2000).
lated state (DeBondt et al., 1993; Schindler et al., 1999; The coupling between the activation loop and helix C
Xu et al., 1999). Both activation loops also interact di- allows for allosteric information to pass between the
rectly with the C helix, stabilizing its inactive conforma- active site and the back of the enzyme, a general phe-
tion (Figure 3). The activation loop and C helix appear nomenon in kinase regulation. In IRK and ERK2, for
to be structurally coupled; a switch in one necessitates example, the conformation of the unphosphorylated ac-
a switch in the other. The binding of cyclin to CDK, in tivation loop is also correlated with structurally distinct
addition to changing the orientation of helix C, also but nonetheless inactive orientations of helix C (Hub-
induces the unphosphorylated activation loop to adopt bard et al., 1994; Zhang et al., 1994).
a conformation similar to that of the fully active form,
which is eventually achieved via phosphorylation by
Pseudosubstrate RegulationCDK-activating kinase (Jeffrey et al., 1995; Russo et al.,
One obvious way to inhibit a kinase is to compete di-1996). Similarly, activation loop phosphorylation of the
rectly with one of its substrates (Kobe and Kemp, 1999).Src family kinase Lck bolsters the active conformation
of helix C (Yamaguchi and Hendrickson, 1996). This was made clear in the very first structure of PKA,
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Figure 4. The Regulation of Protein Kinases by Pseudosubstrate Sequences
Twitchin kinase, CaM kinase, and p21-activated kinase (PAK) are depicted schematically with pseudosubstrate sequences colored yellow.
Disordered regions are shown in dots. The pseudosubstrate segments in twitchin and CaM kinase adopt distinct structures, but both effectively
block the binding of nucleotide and peptide substrate (Hu et al., 1994; Goldberg et al., 1996). The portion of the pseudosubstrate segment in
CaM kinase that interacts directly with Ca2/CaM is shown in orange, and the solvent-exposed tryptophan that anchors the complex is
indicated. In PAK, the pseudosubstrate segment extends from the C terminus of a folded inhibitory switch domain that docks onto the C lobe
of the kinase (Lei et al., 2000). The binding of the inhibitory switch module to the kinase domain directly blocks interaction with peptide
substrate and forces the activation loop to adopt a conformation that prevents the recognition of ATP.
which was solved in complex with the peptide inhibitor that is similar to that observed for twitchin and titin
(Wang et al., 1998).PKI (Knighton et al., 1991). PKI mimics a peptide sub-
strate for the kinase by binding directly to the active The C-terminal pseudosubstrate segment of CaM ki-
nase I (CaMKI), another Ca2/CaM-regulated enzyme,conformation of PKA, without disrupting the binding of
ATP. Indeed, an intramolecular regulatory mechanism induces even more pronounced distortions within the
kinase domain (Goldberg et al., 1996). Here, the pseudo-involving direct competition with substrate had been
proposed prior to the determination of the structure of substrate sequence forms the same initial helix that in-
teracts with the groove within the C lobe of the kinase.PKA (Kemp et al., 1987). The myosin light chain kinase
subfamily of Ca2-responsive enzymes contain C-ter- It then veers sharply and forms a loop and then a second
helix that interacts with and deforms strands 1 and 2minal segments that inhibit catalytic activity until they
are bound by Ca2/calmodulin (Ca2/CaM) or a function- in the N lobe, which together form the phosphate binding
loop crucial for the recognition of ATP (Figure 4). Thisally equivalent Ca2 binding protein. The C-terminal reg-
ulatory motifs contained within the kinase were termed effectively blocks nucleotide binding.
In p21-activated kinase (PAK), the mode of regulation“pseudosubstrate” sequences because they appeared
to compete directly with substrate for access to the by a pseudosubstrate is quite different from that seen
in the Ca2-regulated enzymes (Lei et al., 2000). Ratheractive site. Subsequently, crystal structures of two Ca2-
regulated kinases, twitchin (Hu et al., 1994) and titin than extending directly from the C terminus of the kinase
domain, the pseudosubstrate sequence emerges from(Mayans et al., 1998), were determined, revealing a con-
served mode of autoinhibition. The pseudosubstrate the C terminus of a folded regulatory module called
the inhibitory switch domain, which is N-terminal to thesegment first forms a helix that fits into the same groove
occupied by the helical portion of PKI (Figure 4). The kinase core (Figure 4). The inhibitory switch domain
docks onto the C lobe of the kinase, positioning thechain then snakes into the ATP binding site and out
over the activation loop, blocking the binding of both pseudosubstrate sequence within the active site cleft.
As with CaMKI, this binding induces distortions withinnucleotide and peptide substrate.
The C-terminal extensions of twitchin and titin also the kinase domain itself that further inhibit its catalytic
activity. The activation loop is trapped within the activestabilize the kinase domain in a catalytically inactive
conformation. The presence of the autoinhibitory se- site by the pseudosubstrate segment, where it blocks
ATP binding. In addition, the presence of the activationquence within the active site forces helix C to tip out-
ward, disrupting the crucial Lys-Glu (Lys82-Glu98 in loop within the active site disrupts the Lys-Glu (Lys299-
Glu315 in PAK) ion pair and forces the C helix awaytwitchin, Lys53-Glu68 in titin) ion-pairing interaction. In
addition, the pseudosubstrate segments of twitchin and from the catalytic center.
PAK is activated by the GTP bound forms of certaintitin maintain the N and C lobes in a more open disposi-
tion than seen in the structure of active PKA, an arrange- Rho family G proteins. The inhibitory switch domain
contains within it a CRIB motif that binds to Rac andment incompatible with catalysis. Thus, by stuffing the
mouth of the kinase and prying it open, the C-terminal Cdc42. Structural studies of the WASP protein have
revealed the conformation of the CRIB motif bound toextensions of twitchin and titin go beyond the simple
substrate mimicry of PKI. Interestingly, certain small an activated GTPase, and that conformation is incom-
patible with the recognition of PAK by the CRIB motifmolecule inhibitors of the MAP kinase p38 stabilize the
N and C lobes of the protein in an open conformation (Abdul-Manan et al., 1999). Thus, the binding of G protein
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would dissociate both the inhibitory switch domain and
the pseudosubstrate motif from the kinase, liberating
the enzyme to undergo activation loop phosphorylation.
The pseudosubstrate sequences function as regula-
tors by having two binding partners, the kinase domain
and the activating protein. The binding footprints for
kinase and activator usually overlap only partially, a fea-
ture that may facilitate fast regulatory switching. If the
recognition sites overlap completely, initial access of
the activator to the regulatory sequence would be de-
pendent upon transient dissociation of the inhibitory
segment from the kinase. With partial overlap, the acti-
vator is given access to at least a portion of its binding
site as an anchor from which it can nucleate the remain-
der of the interaction and force off the inhibitor.
The Ca2/CaM recognition site in the regulatory motif
Figure 5. The Regulation of Receptor Kinases by N-Terminal Juxta-of CaMKI, for example, includes the second of the two
membrane Segmentshelices in the inhibitory segment, as well as portions of
EphB2, a receptor tyrosine kinase, and TR-I, a receptor serine/the loop connecting the two helices. A solvent-exposed
threonine kinase, are depicted schematically with their juxtamem-
tryptophan residue that anchors the binding of Ca2/ brane segments colored yellow. In the unphosphorylated state, the
CaM to the inhibitory segment is situated in the loop juxtamembrane region of EphB2 adopts a helical conformation that
and extends away from the kinase, where it is available prevents the C helix and the activation loop from adopting active
conformations (Wybenga-Groot et al., 2001). Phosphorylation of thefor initial interaction with Ca2/CaM (Figure 4; Crivici and
juxtamembrane segment disrupts the inhibitory interactions andIkura, 1995; Goldberg et al., 1996). Similarly, the CRIB
creates binding sites for downstream proteins that contain phos-motif within the inhibitory switch domain of PAK only
photyrosine recognition modules (Dodelet and Pasquale, 2000). The
partially overlaps those parts of the structure that are unphosphorylated juxtamembrane segment of TR-I, which is called
required for autoinhibition. The N-terminal portion of the GS region, maintains the N lobe of the kinase in a distorted,
the CRIB motif is not involved in the formation of the inactive conformation, but only when bound by the inhibitory protein
FKBP12 (Huse et al., 1999). Phosphorylation of the GS region dis-inhibitory switch core and is available to nucleate inter-
rupts the interaction with FKBP12 and creates binding sites foraction with the activated GTPase. As the interaction
substrate proteins of the Smad family (Huse et al., 2001).with the G protein grows, it presumably destabilizes
the folded structure of the inhibitory switch domain,
inducing its dissociation and the adoption of an entirely must be phosphorylated in order to fully activate the
new conformation (Kim et al., 2000; Lei et al., 2000). enzyme (Wieser et al., 1995). When unphosphorylated,
the GS region inhibits the kinase activity of TR-I, but
only when bound by the inhibitory protein FKBP12 (HuseAutoinhibition and Substrate Recruitment
by N-Terminal Segments in EphB2 and TR-I et al., 1999, 2001). The unphosphorylated GS region
forms a helix-loop-helix structure in which the phos-Some groups of kinases are regulated by N-terminal
segments that do not impinge upon the active site di- phorylation sites are located in the loop between the
two helices (the GS loop). When the GS region is boundrectly, but rather inhibit catalytic activity via conforma-
tional change alone. The EphB2 receptor tyrosine kinase by FKBP12, the GS loop adopts an ordered conforma-
tion that is positioned to maintain the N lobe of the kinaseis activated by phosphorylation of the activation loop
and also by phosphorylation of two conserved tyrosines domain in a distorted, inactive conformation (Figure 5).
The C helix is moved away from the N lobe  sheet atin a juxtamembrane region just N-terminal to the kinase
domain. Mutagenesis indicates that the unphosphory- its C terminus and pressed closer to the sheet at its N
terminus. As with EphB2, these conformational changeslated juxtamembrane segment acts as a negative regula-
tor of kinase activity (Dodelet and Pasquale, 2000). The disrupt productive ATP binding.
In the absence of FKBP12, the GS loop becomes flexi-crystal structure of unphosphorylated EphB2 shows that
the juxtamembrane region adopts a helical conforma- ble and no longer adopts an inhibitory conformation
(Huse et al., 2001). Thus, it is the binding of FKBP12tion that impinges upon the N lobe, stabilizing it in a
catalytically inactive conformation (Figure 5; Wybenga- that molds the N-terminal sequence into an inhibitory
motif. While this mode of regulation distinguishes TR-IGroot et al., 2001). The C helix is kinked and moved
closer to the  sheet, where it contacts the glycine-rich from EphB2, it is reminiscent of the autoinhibitory mech-
anism seen in Src family kinases, where the binding ofphosphate binding loop and impedes the proper binding
of nucleotide. The juxtamembrane region of EphB2 also the SH3 domain molds the sequence just N-terminal to
the kinase into a type II polyproline helix, positioning itsterically blocks the activation loop from adopting an
active conformation. to form inhibitory interactions with the N lobe (Sicheri
et al., 1997; Xu et al., 1997).The type I TGF receptor (TR-I), a receptor serine/
threonine kinase, is also activated by phosphorylation The N-terminal segments of EphB2 and TR-I, which
both adopt inhibitory conformations when unphosphor-of an N-terminal regulatory segment. Called the GS re-
gion, this segment is named for a highly conserved ylated, are transformed into binding sites for their appro-
priate physiological substrates in the phosphorylatedTTSGSGSG sequence within it, and 3–4 of the serines
and threonines within this short stretch of amino acids state. EphB2 binds a number of SH2 domains via its
Review
281
in complex with the GTPase-binding domain of the ‘Wiskott-Aldrichjuxtamembrane tyrosines (Dodelet and Pasquale, 2000).
syndrome’ protein. Nature 399, 379–383.The structure of autoinhibited EphB2 reveals that these
Bossemeyer, D., Engh, R.A., Kinzel, V., Ponstingl, H., and Huber, R.binding sites are hidden in the inactive form of the ki-
(1993). Phosphotransferase and substrate binding mechanism ofnase. The juxtamembrane regions of receptor tyrosine
the cAMP-dependent protein kinase catalytic subunit from porcine
kinases such as c-Kit and PDGFR may play a similar heart as deduced from the 2.0 A structure of the complex with Mn2
dual role (Wybenga-Groot et al., 2001). adenylyl imidodiphosphate and inhibitor peptide PKI(5–24). EMBO
The localization of proteins via recognition of phos- J. 12, 849–859.
phoserine/phosphothreonine is also important in eu- Canagarajah, B., Khokhlatchev, A., Cobb, M.H., and Goldsmith, E.J.
(1997). Activation mechanism of the MAP kinase ERK2 by dual phos-karyotic signaling (Yaffe and Elia, 2001). Biochemical
phorylation. Cell 90, 859–869.experiments using TR-I protein phosphorylated homo-
Crivici, A., and Ikura, M. (1995). Molecular and structural basis ofgeneously on four sites within the GS region have dem-
target recognition by calmodulin. Annu. Rev. Biophys. Biomol.onstrated that phosphorylation activates TR-I by creat-
Struct. 24, 85–116.ing a binding site for substrate Smad proteins while
DeBondt, H.L., Rosenblatt, J., Jancarik, J., Jones, H.D., Morgan,simultaneously disrupting the binding of FKBP12 (Huse
D.O., and Kim, S.-H. (1993). Crystal structure of cyclin-dependent
et al., 2001). Smad proteins are transcription factors that kinase 2. Nature 363, 595–602.
are related structurally to the phosphothreonine binding
Dodelet, V.C., and Pasquale, E.B. (2000). Eph receptors and ephrin
FHA domain (Durocher et al., 2000), and mutagenesis ligands: embryogenesis to tumorigenesis. Oncogene 19, 5614–5619.
suggests that a positively charged portion of the Smad Druker, B.J., Talpaz, M., Resta, D.J., Peng, B., Buchdunger, E., Ford,
surface close to the phosphothreonine binding site of J.M., Lydon, N.B., Kantarjian, H., Capdeville, R., Ohno-Jones, S.,
the FHA domain is involved in the binding of phosphory- and Sawyers, C.L. (2001). Efficacy and safety of a specific inhibitor
of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N.lated TR-I (Huse et al., 2001).
Engl. J. Med. 344, 1031–1037.As seen for the overlapping binding sites used in pseu-
Durocher, D., Taylor, I.A., Sarbassova, D., Haire, L.F., Westcott, S.L.,dosubstrate sequences, phosphorylation of the regula-
Jackson, S.P., Smerdon, S.J., and Yaffe, M.B. (2000). The moleculartory motifs in EphB2 and TR-I allows the binding of
basis of FHA domain: phosphopeptide binding specificity and impli-kinase and substrate/effector to be mutually exclusive.
cations for phospho-dependent signaling mechanisms. Mol. Cell 6,
1169–1182.
Eckhart, W., Hutchinson, M.A., and Hunter, T. (1979). An activityConcluding Remarks
phosphorylating tyrosine in polyoma T antigen immunoprecipitates.The structural analysis of protein kinases in their various
Cell 18, 925–933.on and off states has underscored the fact that the
Goldberg, J., Nairn, A.C., and Kuriyan, J. (1996). Structural basis formechanisms of kinase regulation are as varied and com-
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